Evidence map›Paper›PMID 42821008›Full record

ReviewJournal of computer-aided molecular design2026

Uncovering hidden druggable sites: computational approaches to allosteric and cryptic pocket discovery-from molecular dynamics to AI.

Sirish Kaushik Lakkaraju, Olivia Pierce, Ahmet Mentes, Ivy Zhang, John Tokarski, Matthew Chalkley, Jissy Kuriappan, Goutam Mukherjee, Antonio Palmeri, Theresa Johnson and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sirish Kaushik LakkarajuComputational Sciences, Bristol Myers Squibb, Princeton, NJ, 08540, USA. kaushik.lakkaraju@bms.com.
Olivia PierceComputational Sciences, Bristol Myers Squibb, Cambridge, MA, 02141, USA.
Ahmet MentesComputational Sciences, Bristol Myers Squibb, Princeton, NJ, 08540, USA.
Ivy ZhangComputational Sciences, Bristol Myers Squibb, Cambridge, MA, 02141, USA.
John TokarskiComputational Sciences, Bristol Myers Squibb, Princeton, NJ, 08540, USA.
Matthew ChalkleyComputational Sciences, Bristol Myers Squibb, Redwood City, CA, 94063, USA.
Jissy KuriappanBiocon Bristol Myers Squibb R&D Centre, Bangalore, Karnataka, 560099, India.
Goutam MukherjeeBiocon Bristol Myers Squibb R&D Centre, Bangalore, Karnataka, 560099, India.
Antonio PalmeriInformatics & Predictive Sciences, Bristol Myers Squibb, Cambridge, MA, 02141, USA.
Theresa JohnsonComputational Sciences, Bristol Myers Squibb, Cambridge, MA, 02141, USA.
Veerabahu ShanmugasundaramComputational Sciences, Bristol Myers Squibb, Cambridge, MA, 02141, USA. veerabahu.shanmugasundaram@bms.com.ORCID https://orcid.org/0000-0003-0566-6779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allosteric and cryptic binding pockets represent a vast underexploited frontier in drug discovery, offering routes to biological targets historically considered undruggable. The absence of apparent binding pockets in the global conformations of apo structures, together with limitations in availability of chemical probes and experimental structures for novel targets, makes the identification of allosteric and cryptic sites particularly challenging. Despite their ability to reveal transient and otherwise inaccessible pockets, computational methods remain underutilized for allosteric and cryptic site discovery. In this perspective, we present the current state-of-the-art of computational strategies that are available in a computational scientists' toolbox to evaluate the possibility of finding such pockets when assessing a new target in a drug discovery project. Computational approaches span a spectrum from physics-based methods grounded in molecular thermodynamics to AI/ML techniques for identifying allosteric and cryptic binding sites. Physics-based approaches encompass methods operating across multiple scales, from single-conformation analyses that identify pockets based on geometry and energetics (e.g., Fpocket, SiteMap) to molecular simulations that reveal cryptic states and transient binding sites, as well as mixed-solvent and probe-based approaches (e.g., SILCS, MixMD) that delineate druggable hotspots through enhanced sampling. AI/ML methods such as PocketMiner and deep learning cofolding models (AlphaFold3, Boltz) that rapidly predict cryptic sites are discussed in the context of them being over 1,000-fold faster than classical simulations. By surveying current methods and benchmark studies, we aim to define their domains of applicability, highlight their strengths and limitations, and identify opportunities for their integration in prospective drug discovery.

Indexed as

Drug DiscoveryMolecular Dynamics SimulationProteinsAllosteric RegulationAllosteric SiteArtificial IntelligenceBinding SitesHumansLigandsProtein BindingProtein ConformationThermodynamicsLigandsProteinsAI/MLAllosteric SitesCryptic SitesMolecular DynamicsProtein Flexibility

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.